Drugs / PTCy-MILs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02342613 | May 2015 → Nov 2023 | graft versus host disease, hematopoietic and lymphoid cell neoplasm | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTCy-MILs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02342613 ↗ |
| Route | Intravenous | “into a central IV site” NCT02342613 ↗ |